Skip to Content

Methylphenidate Extended-Release Oral Suspension and Chewable Tablets

Last Updated: November 14, 2018
Status: Current

Products Affected - Description
    • Quillivant XR oral powder for suspension, Tris Pharma (formerly Pfizer), 5 mg/mL, 120 mL bottle, NDC 24478-0200-20
    • Quillivant XR oral powder for suspension, Tris Pharma (formerly Pfizer), 5 mg/mL, 150 mL bottle, NDC 24478-0205-25
    • Quillivant XR oral powder for suspension, Tris Pharma (formerly Pfizer), 5 mg/mL, 180 mL bottle, NDC 24478-0210-30
    • Quillivant XR oral powder for suspension, Tris Pharma (formerly Pfizer), 5 mg/mL, 60 mL bottle, NDC 24478-0190-10
Reason for the Shortage
    • Tris Pharma has Quillivant XR on shortage due to manufacturing delays.
    • Tris Pharma has QuillChew ER chewable tablets available.
Available Products
    • QuilliChews chewable tablet, Tris Pharma (formerly Pfizer), 20 mg, bottle, 100 count, NDC 24478-0120-01
    • QuilliChews chewable tablet, Tris Pharma (formerly Pfizer), 30 mg, bottle, 100 count, NDC 24478-0130-01
    • QuilliChews chewable tablet, Tris Pharma (formerly Pfizer), 40 mg, bottle, 100 count, NDC 24478-0140-01

Estimated Resupply Dates

    • Tris Pharma has Quillivant XR 5 mg/mL extended-release oral suspension in 60 mL bottles,120 mL bottles, 150 mL bottles, and 180 mL bottles on back order and the company cannot estimate a release date.

Updated

Updated November 14, 2018 by Stephen Andrews, PharmD, Drug Information Specialist. Created January 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide